Pure Crystalline Standards SRM/RM Description


998 Angiotensin I (Human) 916a Bilirubin


915b Calcium Carbonate 911c Cholesterol


921 Cortisol (Hydrocortisone) 914a Creatinine 917c 920


D-Glucose (Dextrose) D-Mannitol


937 Iron Metal (Clinical) 928 Lead Nitrate


924a Lithium Carbonate


929a Magnesium Gluconate Dihydrate 918b Potassium Chloride 919b Sodium Chloride 1595 Tripalmitin 912a Urea


913a Uric Acid


925 VMA (4-hydroxy-3-methoxy -DL-mandelic acid) 8327 Peptide Reference Material for Molecular Mass and


Purity Measurements


8395 Tissue Engineering Reference, Scaffold 8396 Tissue Engineering Reference, Scaffold 8397 Tissue Engineering Reference, Scaffold


* Values in parentheses are not certified and are given for information only. Molecular Genetics Testing SRM


2392, 2392-I 2399 2372


Description


Mitochondrial DNA Sequencing Fragile X-Human DNA Triplet Repeat Human DNA Quantitation


Human Serum and Milk SRM Description


909b Human Serum


Unit Size 65 µL vial


set (3 


set (9) 1 each)


Purity (%) 94.1


98.3 99.9 99.2 98.9 99.7 99.7 99.8


99.90


100.00 99.9


5.403 Mg 99.9817 99.8 99.5 99.9 99.6 99.4


Unit Size (g) 0.5


0.1 20 2 1


10 50 50 50 30 30 5


30 30 2


25 10 1


Amino Acid Residues Set of 3 Range: 11-26


1 scaffold 1 scaffold 1 scaffold


Peptides 200 300 450


Certified Constituents Calcium, Chloride, Cholesterol,


Creatinine, Lithium, Magnesium, Potassium, Sodium,Total Glycerides, Triglycerides, Urea, and Uric Acid


WWW.NIST.GOV/SRM  PHONE: (301) 975-2200  FAX: (301) 948-3730  EMAIL: SRMINFO@NIST.GOV 13


Reference Bilirubin


Form Lyophilized


No. of Levels


2


HEALTH&CLINICAL


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136